Search | VHL Regional Portal

Using Shame as a Signal to Talk about Suicide.

Siegel, Jacob D; Ko, Christine J.

Clin Chem ; 70(6): 786-788, 2024 Jun 03.

Article in English | MEDLINE | ID: mdl-38441566

Subject(s)

Shame , Suicide , Humans , Suicide/psychology

Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab.

Siegel, Jacob D; Bhatia, Aarti; Ko, Christine J; Christensen, Sean R.

JAAD Case Rep ; 18: 23-25, 2021 Dec.

Article in English | MEDLINE | ID: mdl-34778502

Diltiazem-associated Photodistributed Hyperpigmentation.

Siegel, Jacob D; Ko, Christine J.

Yale J Biol Med ; 93(1): 45-47, 2020 03.

Article in English | MEDLINE | ID: mdl-32226335

ABSTRACT

Diltiazem is a calcium-channel blocker commonly used for the treatment of hypertension. Common adverse effects include dizziness, headache, and edema. Fewer than 20 cases of diltiazem-associated photodistributed hyperpigmentation have been reported in the literature. Here, we present the case of a 71-year-old woman with new-onset facial hyperpigmentation 6 months after initiating treatment with diltiazem.

Subject(s)

Diltiazem/adverse effects , Hyperpigmentation , Hypertension/drug therapy , Photosensitivity Disorders , Skin/pathology , Tacrolimus/pharmacology , Aged , Biopsy , Calcium Channel Blockers/administration & dosage , Calcium Channel Blockers/adverse effects , Dermatologic Agents/pharmacology , Diltiazem/administration & dosage , Female , Humans , Hyperpigmentation/chemically induced , Hyperpigmentation/pathology , Hyperpigmentation/therapy , Ointments , Photosensitivity Disorders/chemically induced , Photosensitivity Disorders/pathology , Photosensitivity Disorders/therapy , Treatment Outcome , Withholding Treatment

Subject(s)

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL